Skip to search formSkip to main contentSkip to account menu

A 64077

Known as: A-64077, Abbot 64077 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The monastery of Homblières, after 949, when it was turned from a community of nuns into a reformed Benedictine monastery under… 
1997
1997
The effects of the orally active selective 5-lipoxygenase inhibitor Zileuton (A-64077, (N-1(1-benzo{b}thien-2-ylethyl)-N… 
1994
1994
This study was designed to characterize the role of arachidonate 5-lipoxygenase metabolism during experimental intestinal… 
Highly Cited
1992
Highly Cited
1992
Investigation of the SAR of the lead (methoxyalkyl)thiazole 1-[3-(naphth-2-ylmethoxy)phenyl]-1-thiazol-2-ylprop yl methyl ether… 
1992
1992
We examined the effects of an inhibitor of 5-lipoxygenase (A-64077) in 11 patients with mild to moderately active ulcerative… 
1992
1992
The role of leukotrienes in the pathogenesis of acute gastric ulceration induced by nonsteroidal antiinflammatory drugs was… 
1992
1992
1 Peritoneal mast cells from rat were co‐incubated in vitro in a platelet aggregometer cuvette with washed rabbit platelets. In… 
Highly Cited
1991
Highly Cited
1991
The effect of a single oral dose (800 mg) of zileuton (A-64077), a specific 5-lipoxygenase inhibitor, on the early and late… 
1991
1991
The potency and reversibility of a new orally active 5-lipoxygenase (5-LO) inhibitor were evaluated in human volunteers. Zileuton…